Ember Therapeutics, Inc. - Ny Watch

from 8-K 6 pages Asset Purchase Agreement

from 8-K 4 pages First Amendment to Distribution, License and Supply Agreemententered Into as of the 22ndday of June, 2016 (The "First Amendment") Between: Knight Therapeutics Inc., a Corporation Formed Under the Laws of Canada; (Hereinafter Called the "Knight"). And: Ember Therapeutics, Inc., a Corporation Formed Under the Laws of the State of Delaware; (Hereinafter Called the "Ember") 1. Amendments 1.1 Amendments to the Distribution Agreement the Borrower and the Lender Hereby Agree to Amend the Distribu Tion Agreement as Follows: 1.1.1 Section 1.1 of the Distribution Agreement Is Amended by Restating the Following Definitions

from 8-K 62 pages Asset Purchase Agreement Dated as of March 18, 2016 Between Migralex, Inc. and Ember Therapeutics, Inc. 1 Asset Purchase Agreement

from 8-K 58 pages Asset Purchase Agreement Dated as of March 15, 2016 Between Intercytex, Ltd. and Ember Therapeutics, Inc. 1 Asset Purchase Agreement

from 8-K 4 pages Indemnity Agreement

from 8-K 8 pages Conversion and Registration Rights Agreement

from 8-K 8 pages Office Sharing Agreement

from 8-K 31 pages Distribution, License and Supply Agreement

from 8-K 9 pages General Security Agreement

from 8-K 28 pages License Agreement

from 8-K 4 pages January 13, 2016 Third Rock Ventures II, L.P. Attn: Kevin Gillis 29 Newbury Street Boston, Ma 02116 Re: Implications of Reverse Merger Dear Mr. Gillis

from 8-K 5 pages Convertible Promissory Note

from 8-K 26 pages Agreement and Plan of Merger

from 8-K 8 pages Mariel Therapeutics, Inc. Second Amended and Restated Secured Promissory Note

from 8-K 8 pages Amendment No. 2 to Asset Purchase Agreement

from 8-K 4 pages Amendment No. 1 to Asset Purchase Agreement

from 8-K 54 pages Asset Purchase Agreement by and Among Stryker Corporation, Stryker Biotech L.L.C. and Mariel Therapeutics, Inc. Dated as of June 30, 2014 1

from 8-K 6 pages Consulting Agreement